Amoxicillin + Clavulanic acid
Hiconcil combi is an antibiotic that works bactericidally on bacteria that cause infections.
Hiconcil combi contains two different ingredients: amoxicillin and clavulanic acid. Amoxicillin
belongs to a group of medicines called "penicillins", whose action may sometimes be inhibited
(inactivated). The second active ingredient (clavulanic acid) counteracts this inactivation.
Hiconcil combi is used in adults and children to treat the following infections:
Hiconcil combi.In case of doubt, before starting treatment with Hiconcil combi, consult your doctor or
pharmacist.
Before starting treatment with Hiconcil combi, discuss it with your doctor or pharmacist if the patient:
In case of doubt whether the above circumstances apply to the patient, consult a doctor or pharmacist before starting treatment with Hiconcil combi.
In some cases, the doctor may examine what type of bacteria caused the patient's infection. Depending on the results, the patient may receive Hiconcil combi in a different dose or a different medicine.
Taking Hiconcil combi may worsen the course of some diseases or cause severe side effects, including allergic reactions, seizures, and colitis. You should pay attention to whether the patient has certain symptoms during treatment with Hiconcil combi to minimize the risk of any problems. See "Conditions to watch out for" in section 4.
If the patient is to have blood tests (such as red blood cell tests or liver function tests) or urine tests (for glucose), inform the doctor or nurse that the patient is taking Hiconcil combi. Hiconcil combi may affect the results of these tests.
Tell your doctor or pharmacist about all medicines the patient is taking, has recently taken, or plans to take.
If the patient is taking allopurinol (used in gout) at the same time as Hiconcil combi, it is more likely that the patient will experience skin allergic reactions.
If the patient is taking probenecid (used in gout), the doctor may decide to modify the dose of Hiconcil combi.
If the patient is taking blood-thinning medicines (such as warfarin) at the same time as Hiconcil combi, additional blood tests may be necessary.
Hiconcil combi may affect the action of methotrexate (a medicine used to treat cancer or rheumatic diseases).
Hiconcil combi may affect the action of mycophenolate mofetil (a medicine used to prevent transplant rejection).
Hiconcil combi should be taken at the beginning of a meal or just before a meal.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Hiconcil combi may cause side effects and symptoms that can impair the ability to drive vehicles.
Do not drive vehicles or operate machines unless the patient feels well.
The medicine contains 2.5 mg of aspartame in each ml of suspension. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper excretion.
15.8 ml of suspension contains 1 mmol (39 mg) of potassium, which should be taken into account in patients with reduced kidney function and in patients controlling their potassium intake.
This medicine should always be taken/administered according to the doctor's or pharmacist's instructions. In case of doubt, consult a doctor or pharmacist.
This suspension is not usually recommended for adults and children with a body weight of 40 kg or more. Consult a doctor or pharmacist for advice.
All doses are determined based on the child's body weight.
Strength | Package size (ml) | Volume of water to be added to prepare the suspension (ml) - see also: the line marked on the bottle indicating the amount of water needed to prepare the suspension |
Before each use, shake the bottle with the medicine energetically.
If the patient has taken a larger dose of Hiconcil combi than recommended, they may experience symptoms such as stomach upset (nausea, vomiting, or diarrhea) or seizures. Contact a doctor as soon as possible. Have the carton or bottle of medicine with you to show the doctor.
Do not take a double dose to make up for a missed dose. If the patient forgets to take a dose, they should take it as soon as they remember. Do not take the next dose too early, wait about 4 hours before taking the next dose.
Continue taking Hiconcil combi until the end of the treatment, even if the patient feels better. All doses of the medicine are needed to fight the infection. If some bacteria survive, they may cause the infection to recur.
In case of any further doubts about taking this medicine, consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of these symptoms occur, contact a doctor immediately.
Colitis, causing watery diarrhea usually with blood and mucus, abdominal pain, and (or) fever.
(400 mg + 57 mg)/5 ml | 30 | 25 |
60 | 56 | |
70 | 61 | |
100 | 87 |
If the patient has severe and persistent stomach pain, it may be a sign of acute pancreatitis.
Drug-induced enterocolitis syndrome occurred mainly in children receiving amoxicillin with clavulanic acid. It is a type of allergic reaction, whose leading symptom is repeated vomiting (1 to 4 hours after taking the medicine). Further symptoms may include abdominal pain, lethargy, diarrhea, and low blood pressure.
If any of these symptoms occur, contact a doctor as soon as possible for advice.
Very common (may occur more often than in 1 in 10 patients)
Common (may occur no more often than in 1 in 10 patients)
Hiconcil combi should be taken before meals if the patient experiences:
Uncommon (may occur no more often than in 1 in 100 patients)
Uncommon side effects that may appear in blood test results:
Rare (may occur no more often than in 1 in 1000 patients)
Rare side effects that may appear in blood test results:
Frequency not known: cannot be estimated from the available data
Side effects that may appear in blood or urine test results:
If side effects occur, including any side effects not listed in this leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medicine.
Keep the medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date refers to the last day of the month.
Powder for oral suspension:
Store in a temperature below 25°C.
Store in the original packaging to protect from moisture.
Reconstituted suspension:
Store in the refrigerator (2°C - 8°C).
Shelf life of the reconstituted suspension (medicine after adding water): 7 days.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White to almost white powder, which after dissolution in water gives a white to almost white suspension with a fragrant, fruity smell.
HDPE bottle with a level indicator for reconstitution, a PP child-resistant cap ("CRC cap"), and a dosing syringe made of polystyrene with a scale from 0.5 ml to 5 ml, every 0.5 ml, in a carton containing: 6 g, 12 g, 14 g, or 20 g of powder for preparation, respectively, 30 ml, 60 ml, 70 ml, or 100 ml of oral suspension.
Not all pack sizes may be marketed.
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
This medicine is authorized in the Member States of the European Economic Area under the following names:
TAD Pharma GmbH | |
Heinz-Lohmann-Straße 5 | |
27472 Cuxhaven | |
Germany |
Product name |
Croatia, Czech Republic, Estonia, Lithuania, Latvia, Slovakia, Slovenia, Hungary | Betaklav |
Bulgaria | Бетаклав (Betaklav) |
Poland | Hiconcil combi |
For more information about this medicine, contact the local representative of the marketing authorization holder:
KRKA-POLSKA Sp. z o.o.
ul. Równoległa 5
02-235 Warsaw
phone: 22 57 37 500
Antibiotics are used to treat bacterial infections. They are ineffective in treating viral infections.
Sometimes bacterial infections do not respond to antibiotic treatment.
One of the most common reasons for this phenomenon is that bacteria are resistant to the administered antibiotic.
This means that bacteria can survive or multiply despite the use of an antibiotic.
Bacteria can become resistant to antibiotics for many reasons. Careful use of antibiotics can help reduce the possibility of bacteria developing resistance.
The antibiotic prescribed by the doctor is intended solely for the treatment of the current illness. Paying attention to the following tips will help prevent the development of resistant bacteria that could hinder the effectiveness of the antibiotic.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.